期刊文献+

宫颈癌盆腔组织校正对放疗剂量学影响的研究 被引量:3

Study on the Impact of Correction or Non-correction for Pelvic Cavity Tissue on Dosimetry in Cervical Carcinoma Patients
下载PDF
导出
摘要 目的比较不均匀盆腔组织校正对宫颈癌患者的肿瘤靶区、正常组织及重要器官放疗剂量分布的影响。方法选择9例经病理证实为原发性宫颈癌的患者,每例患者同时设计两组治疗计划,模拟常规放疗不校正不均匀盆腔组织计划(计划1)、三维适形放疗(3DCRT)校正不均匀盆腔组织计划(计划2)。计划1为前后左右对穿照射50 Gy,通过调节剂量权重使处方剂量与常规放疗的相同;射野大小、其他参数与常规放疗的相同,此时得到计划1的剂量分布就是常规不校正不均匀盆腔组织在患者体内的实际分布。计划2为3DCRT照射50 Gy。将计划1与计划2进行比较。结果计划2 PTV的Dmax和Dmean均较计划1高(P<0.05);计划2均匀性指数(HI)、适形度指数(CI)值均较计划1大(P<0.05);计划2膀胱、直肠、小肠、左右侧股骨头的Dmean均较计划1低(P<0.05)。结论 3DCRT校正不均匀盆腔组织更合理。 Objective To explore the impact of correction for non-uniform pelvic cavity tissue on the dose distribution of gross tumor target,normal tissue and organs at risk of patients with cervical carcinoma. Methods Night cases of cervical carcinoma were enrolled in the study. Two radiotherapy plans were designed for each case:plan of non-correction in routine radiotherapy for non-uniform pelvic cavity tissue (Plan 1 ), plan of correction in 3-dimensional conformal radiotherapy (3DCRT) for non-uniform pelvic cavity tissue(Plan 2). Plan 1 included 50 Gy irradiation for anterior and posterior fields, making prescription dose same as that of the routine radiotherapy by adjusting the dose weight, and the irradiation field size and other parameters same as those of the routine radiotherapy. Then the dose distribution of Plan 1 was the actual distribution in the patient's body at the moment. Plan 2 included 50 Gy irradiation of 3DCRT. The dose distributions of Plan 1 and Plan 2 were compared. Results Dmax and Dmean of PTV of Plan 2 were higher than those of Plan 1 (P 〈 0.05 ). Values of homogeneity index(HI) and conformity index(CI) of Plan 2 were larger than those of Plan 1 (P 〈 0.05 ). Dmeans of bladder, small intestine, left and right thiqhbone of Plan 2 were lower than those of Plan 1 (P 〈 0.05). Conclusion Correction in 3DCRT is more reasonable for non-uniform pelvic cavity tissue.
出处 《广西医学》 CAS 2012年第7期827-830,共4页 Guangxi Medical Journal
基金 广西科学研究与技术开发计划项目(桂科攻10124001B-59)
关键词 宫颈癌 盆腔组织 放射疗法 三维适形 常规 剂量分布 Cervical carcinoma Pelvic cavity tissue Radiotherapy Three dimensional conformal radiotherapy Routine Dose distribution
  • 相关文献

参考文献10

  • 1乔友林.在发展中国家与地区开展子宫颈癌防治的前景[J].癌症,2010,29(1):1-3. 被引量:25
  • 2郝敏,王静芳.宫颈癌流行病学研究与调查[J].国外医学(妇幼保健分册),2005,16(6):404-406. 被引量:91
  • 3ICRU. Prescribing, recording, and reporting therapy[ R]. ICRU Report No. 50,1993.
  • 4ICRU. Prescribing, recording, and reporting therapy[ R ]. ICRU Report No. 62,1999. photon beam photon beam.
  • 5杨瑞杰,姜伟娟,王俊杰.射线能量对子宫内膜癌调强放疗计划质量的影响[J].中华放射医学与防护杂志,2009,29(5):495-498. 被引量:13
  • 6Feuvret L,Noel G,Mazeron JJ ,et al. Conformity index:a review [ J ]. Int J Radiat Oncol Biol Phys ,2006,64(2) :333 - 342.
  • 7林原,周莉均,徐志勇,蔡树模,李子庭,傅小龙,章真,郭小毛,蒋国梁.宫颈癌术后盆腔三维适形与调强放疗剂量学与技术的研究[J].中华放射肿瘤学杂志,2008,17(5):372-376. 被引量:42
  • 8Xiao Y, Papiez L, Paulus R, et al. Dosimetric evaluation of heterogeneity corrections for RTOG:0236: stereotactic body radiotherapy of inoperable stage Ⅰ - Ⅱ non-small cell lung cancer[ J ]. Int J Radiat Oncol Biol Phys, 2009,73 ( 4 ) : 1 235 -1 242.
  • 9Ding GX, Duggan DM, Lu B, et al. Impact of inhomogeneity corrections on dose coverage in the treatment of lung cancer using stereotactic body radiation therapy [ J ]. Med Phys, 2007,34(7) :2 985 -2 994.
  • 10Papanikolaou N, Klein EE. Heterogeneity corrections should be used in treatment planning for lung cancer [ J ]. Med Phys,2000,27(8) :1 702- 1 704.

二级参考文献65

  • 1Chen SW, Liang JA, Yang SN, et al. Postoperative radiotherapy for patients with invasive cervical cancer following treatment with simple hysterectomy. JPN J Clin Oncol,2003,33:477-481
  • 2Roeske JC, Lujan A, Rotmennsch J, et al. Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies. Int J Radiat Oncol Biol Phys,2000,48:1613-1621
  • 3Mundt A J, Roeske JC, Lujan AE, et al. Initial clinical experience with intensity-modulated whole pelvis radiation therapy in women with gynecologic malignancies. Gynecol Oncol,2001,82 :456-463
  • 4Portelance L, Chao KSC, Grigsby PW, et al. Intensity-modulated radiation therapy(IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation. Int J Radiat Oncol Biol Phys,2001,51: 261-266.
  • 5Heron DE,Gerszten K,Selvaraj RN,et al. Conventional 3D conforreal versus intensity- modulated radiotherapy for the adjuvant treatment of gynecologic malignancies: a comparative dosimetrie study dose-volume histograms. Gynecol Oncol,2003,91: 39-45.
  • 6Low DA, Grigsby PW, Dempsey JF, et al. Applicator-guided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys, 2002,52 : 1400-1406.
  • 7Huh SJ,Kang MK,Han Y,et al. Small bowel displacement systemassisted intensity- modulated radiotherapy for cervical cancer. Gynecol Oncol,2004,93:400-406.
  • 8Huh SJ,Park W,Han Y,et al. Interfractionall variation in position of the uterus during radical radiotherapy for cervical cancer. Radiother Oncol,2004,71:73-79.
  • 9Lujan AE, Mundt A J, Yamada SD, et al. Intensity modulated radiotherapy as a means of reducing dose to bone marrow in gynecologic patients receiving whole pelvic radiotherapy. Int J Radiat Oncol Biol Phys ,2003,57:516-521.
  • 10Feuvret L,Noel G,Mazeron JJ,et al. Conformity index: a review. Int J Radiat Oncol Biol Phys,2006,64:333-342.

共引文献160

同被引文献27

  • 1于金明,于甬华.放射治疗的质量保证与质量控制[J].中国肿瘤,2004,13(8):473-477. 被引量:27
  • 2张春丽,李乾,左力,崔盈,王彦福,郭凤琴,赵光宇,张旭初,周玉红,王荣福.肾动态显像法与双血浆法测定肾小球滤过率的对比分析[J].北京大学学报(医学版),2004,36(6):612-615. 被引量:32
  • 3刘跃平,刘新帆,李晔雄,关莹.膀胱充盈状态对前列腺癌三维适形放疗靶区和重要器官的影响[J].中华放射肿瘤学杂志,2007,16(1):48-51. 被引量:19
  • 4UDEANI GO, GERHAUSER C, THOMAS CF, et al. Cancer chemopreventive activity mediated by deguelin, a naturally occurring retenoid[J]. Cancer Res, 1997, 57(16): 3424-3428.
  • 5YAN Y, WANG Y, TAN Q, et al. Efficacy of deguelin and sili- binin on benzo(a) pyrene-induced lung tumorigenesis in A/J mice [J]. Neoplasia, 2005, 7(12): 1053-1057.
  • 6OH SH, WOO JK, YAZICI YD, et al. Structural basis for depletion of heat shock protein 90 client proteins by degudin[J]. J Natl Cancer Inst, 2007, 99(12): 949-961.
  • 7CHUN KH, KOSMEDER JW, SUN S, et al. Effects of deguelin on the phosphatidylinositol 3-kinase/Akt pathway and apoptosis in premalignant human bronchial epithelial cells[J]. J Nail Cancer Inst, 2003, 95(4): 291-302.
  • 8MURILLO G, SALTI GI, KOSMEDER JW, et al. Deguelin inhibits the growth of colon cancer cells through the induction of apotosis and cell cycle arrest[J]. Eur J Cancer, 2002, 38(18): 2446-2454.
  • 9WONG RS. Apoptosis in cancer: from pathogenesis to treatment [J]. J Exp Clin Cancer Res, 2011, 30(1): 87.
  • 10FANG N, CASIDA JE. Anticancer action of cube insecticide: correlation for rotenoid constituents between inhibition of NADH: ubiquinone oxidoreductase and induced omithine decarboxylase activities[J]. Proc Nail Acad Sci USA, 1998, 95(7): 3380-3384.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部